Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
While both agents target different pathways, their combination has not been extensively studied and may increase side effect risks without proportional efficacy gains
Abbreviations EOC: Epithelial ovarian cancer OCCC: Ovarian clear cell carcinoma OEC: Endometrioid carcinoma ARID1A: AT-rich interactive domain-containing protein 1A PIK3CA: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha PTEN: Phosphatase and tensin homolog KRAS: KRAS proto-oncogene TP53: Tumor protein p53 EAOC: Endometriosis-associated ovarian cancer SIR: Standardized incidence ratio CI: Confidence interval ER: Estrogen receptor beta ER: Estrogen receptor alpha BDNF: Brain-derived neurotrophic factor TrkB: Tropomyosin receptor kinase B (NTRK2) IHC: Immunohistochemistry ERE: Estrogen response element RTK: Receptor tyrosine kinase PI3K: Phosphatidylinositol 3-kinase AKT: Protein kinase B EMT: Epithelialmesenchymal transition TME: Tumor microenvironment MAPK/ERK: Mitogen-activated protein kinase/extracellular signal-regulated kinase JAK/STAT: Janus kinase/signal transducer and activator of transcription OR: Odds ratio HR: Hazard ratio IC50: Half maximal inhibitory concentration p-AKT: Phosphorylated AKT p-ERK: Phosphorylated ERK mTOR: Mechanistic target of rapamycin FFPE: Formalin-fixed, paraffin-embedded References Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG
How to Use BPC 157 BPC 157 can be administered through various methods, including intraperitoneally, intravenously, or via local applications such as enemas and creams
We carefully source our ingredients from trusted, reputable suppliers and verify their identity, purity, and potency before use
